deltatrials
Not Yet Recruiting PHASE1 INTERVENTIONAL 4-arm NCT07326878

Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine

A Single-center, Randomized, Double-blind, and Placebo Controlled Phase Ⅰ Clinical Trial of the Safety and Preliminary Immunogenicity of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine in People Aged 6 Months to 59 Years

Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences

Conditions HFMD Hand, Foot and Mouth Disease Hand, Foot and Mouth Disease (HFMD)
Interventions High Dose Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine, inactivated (human diploid cell) Low Dose Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine, inactivated (human diploid cell) Medium Dose Enterovirus Type71 - Coxsackievirus Type A16 bivalent vaccine, inactivated (human diploid cell) Placebo
Updated 1 time since 2026 Last updated: Dec 26, 2025 Started: Dec 30, 2025 Primary completion: Aug 15, 2026 Completion: Aug 15, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07326878, this PHASE1 trial focuses on HFMD and Hand, Foot and Mouth Disease and remains actively recruiting participants. Sponsored by Institute of Medical Biology, Chinese Academy of Medical Sciences, it has been updated 1 time since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Feb 2026 – present · 5 months · monthly snapshotNot Yet Recruiting

Change History

1 version recorded
Not Yet Recruiting — PHASE1 [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institute of Medical Biology, Chinese Academy of Medical Sciences
  • The Second Affiliated Hospital of Chongqing Medical University
Data source: Institute of Medical Biology, Chinese Academy of Medical Sciences

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations